Serina Therapeutics, Inc.
SER
$5.84
$0.081.39%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 42.85% | -417.31% | -457.17% | -1,154.55% | -3,471.56% |
| Total Depreciation and Amortization | 82.35% | 115.56% | 43.57% | 122.22% | 68.32% |
| Total Amortization of Deferred Charges | 1,368.18% | -- | -- | -- | -- |
| Total Other Non-Cash Items | -235.76% | 131.86% | 148.98% | 238.37% | 418.45% |
| Change in Net Operating Assets | -1,152.96% | -4,395.06% | -2,887.62% | -1,239.99% | 20.67% |
| Cash from Operations | -494.56% | -592.12% | -259.57% | -273.50% | -41.43% |
| Capital Expenditure | 98.46% | 95.63% | 80.39% | 37.48% | -5,240.21% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 98.46% | 95.63% | 80.39% | 37.48% | -206.67% |
| Total Debt Issued | -73.21% | -69.87% | -78.82% | -80.30% | -83.97% |
| Total Debt Repaid | -210.00% | -250.00% | 95.13% | 95.02% | 98.65% |
| Issuance of Common Stock | 52,515.79% | 66,566.67% | 26,075.26% | 92,603.70% | 331.82% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1,358.75% | -- | -- | -- | -- |
| Cash from Financing | 469.14% | 31.24% | -19.71% | -27.57% | -76.02% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -288.32% | -155.69% | -169.28% | -132.49% | -112.29% |